Side effects of glucocorticoids: in vivo models and underlying mechanisms
Open Access
- 5 August 2025
- journal article
- review article
- Published by Springer Nature in Discover Medicine
- Vol. 2 (1) , 1-14
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Russian Science Foundation (23-15-00321, 23-15-00321, 23-15-00321, 23-15-00321, 23-15-00321, 23-15-00321, 23-15-00321)
This publication has 122 references indexed in Scilit:
- Berberine ameliorates glucocorticoid-induced hyperglycemia: an in vitro and in vivo studyNaunyn-Schmiedeberg's Archives of Pharmacology, 2023
- Obestatin signalling counteracts glucocorticoid‐induced skeletal muscle atrophy via NEDD4/KLF15 axisJournal of Cachexia, Sarcopenia and Muscle, 2021
- Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopeniaOsteoporosis International, 2019
- Preventative effects of metformin on glucocorticoid-induced osteoporosis in ratsJournal of Bone and Mineral Metabolism, 2019
- Glucocorticosteroids2016
- Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strengthOsteoporosis International, 2015
- Steroid‐induced diabetes: a clinical and molecular approach to understanding and treatmentDiabetes/Metabolism Research and Reviews, 2013
- Developmentally regulated inhibition of cell cycle progression by glucocorticoids through repression of cyclin a transcription in primary osteoblast culturesJournal of Cellular Physiology, 2010
- Guidelines for assessment of bone microstructure in rodents using micro–computed tomographyJournal of Bone and Mineral Research, 2010
- Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF‐κB‐independent, FoxO1‐dependent mechanismJournal of Cellular Physiology, 2006